Related Articles

• Sorafenib-induced reversible posterior leukoencephalopathy in patients with renal cell carcinoma: A report of two cases
• Reversible posterior leukoencephalopathy associated with chronic graft-versus-host disease: A case report
• Reversible posterior leukoencephalopathy syndrome secondary to systemic-onset juvenile idiopathic arthritis: A case report and review of the literature
• Potential biomarkers for the therapeutic efficacy of sorafenib, sunitinib and everolimus
• Reversible posterior leukoencephalopathy syndrome following combinatorial cisplatin and pemetrexed therapy for lung cancer in a normotensive patient: A case report and literature review